ENTITY
Merck & Co

Merck & Co (MRK US)

244
Analysis
Health CareUnited States
Merck & Co., Inc. is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company has operations in pharmaceutical, animal health, and consumer care.
more
29 Jun 2018 12:38

This Week in Blockchain & Cryptos: Blockchain for Football 🏆⚽ Talent Management & Piracy Prevention

From missed penalties to a shocking German exit this week, this has been by far the most action-packed World Cup we have had in a long time. Such...

Logo
360 Views
Share
bearishEisai Co Ltd
17 May 2018 19:14

Eisai FY17 Earnings - First Glance

Eisai Co Ltd (4523 JP) reported FY17 results on May 15, 2018 Lenvima sales ramp-up + Upfront payment from Merck led FY17 topline growth and gross...

18 Apr 2018 19:24

Ono’s Stock Price Decline on Merck’s KN-189 Success

On April 16, 2018, the topline data for Ono Pharmaceutical Co Ltd (4528 JP) Opdivo and Merck & Co. Inc. (MRK US) Keytruda, both as a...

01 Mar 2018 08:44

Will Actinogen Ace Alzheimer's?

Alzheimer’s disease is an incurable neurodegenerative disorder that robs the affected individuals of memory, self-care and quality of life,...

Logo
359 Views
Share
bullishMerck & Co
22 Feb 2018 21:25

Is Merck Paying Peanuts to Viralytics for Full Access to Its Oncolytic Immunotherapy Drug Candidate?

The Merck DealThe competition between the leading checkpoint inhibitor cancer drugs Opdivo/Yervoy (Bristol Myers Squibb Co (BMY US) ) and Keytruda...

Logo
362 Views
Share
x